Pharma co Boehringer Ingelheim partners with blockchain firm for diabetes care – Ledger Insights
- Care announced it has partnered with Boehringer Ingelheim Pharmaceuticals Inc to create the Diabetes Care Administration Network.
- The digital network aims to streamline treatment for type 2 diabetes patients.
- The Estonia based firm’s technology will be applied to the type 2 diabetes-focused network to allow patients to coordinate their care with doctors and families easily.
Read full article: ledgerinsights.com